NKTR vs W · rev $21.0M vs rev $6.45B
Nektar Therapeutics (NKTR) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
Latest reported W revenue for 2026-06-30 was $6.45B. Net income was -$106.0M. W currently screens at market cap $10.77B.
NKTR currently screens at market cap $307.2M. W currently screens at market cap $10.77B.
Not investment advice. Open the NKTR and W stock pages for the full models.
Not investment advice.